These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10121013)

  • 1. Potential for microbial contamination of ADD-Vantage admixtures.
    Hudson TJ; Ambroziak EM; Coley RM
    J Pharm Technol; 1992; 8(5):195-7. PubMed ID: 10121013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of two work practice changes on the microbial contamination rates of pharmacy-compounded sterile preparations.
    Trissel LA; Gentempo JA; Saenz LM; Woodard MY; Angeles CH
    Am J Health Syst Pharm; 2007 Apr; 64(8):837-41. PubMed ID: 17420200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbial contamination of syringes during preparation: the direct influence of environmental cleanliness and risk manipulations on end-product quality.
    Stucki C; Sautter AM; Favet J; Bonnabry P
    Am J Health Syst Pharm; 2009 Nov; 66(22):2032-6. PubMed ID: 19890087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of two sterility testing methods for intravenous admixtures.
    Condella F; Eichelberger K; Foote LC; Griffin RE
    Hosp Pharm; 1980 Jun; 15(6):305-10. PubMed ID: 10247270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. I.V. admixture contamination rates: traditional practice site versus a class 1000 cleanroom.
    Thomas M; Sanborn MD; Couldry R
    Am J Health Syst Pharm; 2005 Nov; 62(22):2386-92. PubMed ID: 16278330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of laminar air flow and clean-room dress on contamination rates of intravenous admixtures.
    Brier KL; Latiolais CJ; Schneider PJ; Moore TD; Buesching WJ; Wentworth BC
    Am J Hosp Pharm; 1981 Aug; 38(8):1144-7. PubMed ID: 7270557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Auditing sterile compounding competency with video observation.
    Connor TK; Lim JH; Hinton TM
    Am J Health Syst Pharm; 2017 Aug; 74(16):1218-1219. PubMed ID: 28790073
    [No Abstract]   [Full Text] [Related]  

  • 8. Economic assessment of aseptic compounding rooms in hospital pharmacies in five European countries.
    Dekyndt B; Décaudin B; Lannoy D; Odou P
    J Oncol Pharm Pract; 2015 Apr; 21(2):102-10. PubMed ID: 24519187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiologic quality assurance for intravenous admixtures in a small hospital.
    Doss HL; James JD; Killough DM; Snodgrass GL
    Am J Hosp Pharm; 1982 May; 39(5):832-5. PubMed ID: 6805321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of the aseptic processing environment.
    Frieben WR
    Am J Hosp Pharm; 1983 Nov; 40(11):1928-35. PubMed ID: 6650522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using a medium-fill simulation to evaluate the microbial contamination rate for USP medium-risk-level compounding.
    Trissel LA; Gentempo JA; Anderson RW; Lajeunesse JD
    Am J Health Syst Pharm; 2005 Feb; 62(3):285-8. PubMed ID: 15719586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Codes + standards. Pharmacy facts. Architectural and environmental changes required for USP 797.
    Bernstein WN
    Health Facil Manage; 2005 Jul; 18(7):39-40. PubMed ID: 16130375
    [No Abstract]   [Full Text] [Related]  

  • 13. ASHP--hospital intravenous admixture program certification.
    Turco S
    Hosp Pharm; 1978 Jun; 13(6):306, 356. PubMed ID: 10307642
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of microbial contamination associated with different preparation methods for neonatal intravenous fat emulsion infusion.
    Crill CM; Hak EB; Robinson LA; Helms RA
    Am J Health Syst Pharm; 2010 Jun; 67(11):914-8. PubMed ID: 20484215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial: Solving problems associated with large-volume parenterals. I: pharmacist responsibility for compounding intravenous admixtures.
    Zellmer WA
    Am J Hosp Pharm; 1975 Mar; 32(3):255. PubMed ID: 1136972
    [No Abstract]   [Full Text] [Related]  

  • 16. Parenterals laboratory course to reduce microbial contamination rates in media fill tests performed by pharmacy students.
    Isanhart CM; McCall KL; Kretschmer D; Grimes BA
    Am J Pharm Educ; 2008 Apr; 72(2):27. PubMed ID: 18483595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bacteriological quality of air in a ward for sterile pharmaceutical preparations].
    Caorsi P B; Sakurada Z A; Ulloa F MT; Pezzani V M; Latorre O P
    Rev Chilena Infectol; 2011 Feb; 28(1):14-8. PubMed ID: 21526280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential for airborne contamination in turbulent- and unidirectional-airflow compounding aseptic isolators.
    Peters GF; McKeon MR; Weiss WT
    Am J Health Syst Pharm; 2007 Mar; 64(6):622-31. PubMed ID: 17353571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compounding parenteral nutrition: reducing the risks.
    Curtis C; Sacks GS
    Nutr Clin Pract; 2009; 24(4):441-6. PubMed ID: 19605798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A virtual clean room to teach USP 797 regulations for intravenous medications.
    Patel S; Vincent AH; Abel SR; Jacobs CM; Dunlop SR; Seibert M
    Am J Pharm Educ; 2011 Feb; 75(1):7. PubMed ID: 21451759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.